Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
29.9M
-
Shares change
-
+873K
-
Total reported value, excl. options
-
$2.26B
-
Value change
-
+$69.3M
-
Put/Call ratio
-
0.53
-
Number of buys
-
118
-
Number of sells
-
-91
-
Price
-
$75.73
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2023
248 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q1 2023.
TransMedics Group, Inc. - Common Stock (TMDX) has 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.9M shares
of 33.9M outstanding shares and own 88.05% of the company stock.
Largest 10 shareholders include FMR LLC (3.26M shares), BlackRock Inc. (2.25M shares), LORD, ABBETT & CO. LLC (1.85M shares), MACQUARIE GROUP LTD (1.75M shares), VANGUARD GROUP INC (1.72M shares), FRED ALGER MANAGEMENT, LLC (1.14M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.07M shares), Sandhill Capital Partners LLC (988K shares), Allspring Global Investments Holdings, LLC (948K shares), and SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (906K shares).
This table shows the top 220 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.